홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ICCC
#3451
Immucell Corp
6.4
0
+0.79%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+0.79%
월간 변동
+0.63%
6달 변화
+4.40%
년간 변동율
+21.67%
이전 종가
6.3
5
Open
6.4
0
Bid
Ask
Low
6.4
0
High
6.4
0
양
3
마켓
주식
헬스케어
ICCC
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
7.22 M
7.74 M
7.75 M
7.75 M
8.98 M
—
Valuation ratios
Enterprise value
36.01 M
51.76 M
44.41 M
60.1 M
46.01 M
204.41 M
Price to earnings ratio
42.5
-800.01
-20.25
-6.67
-19.81
-86.37
Price to sales ratio
2.8
3.16
2.7
2.22
1.59
7.13
Price to cash flow ratio
32.62
63.66
-32.51
-8.29
117.52
199.16
Price to book ratio
1.52
1.86
1.65
1.55
1.53
2.9
Enterprise value to EBITDA ratio
37.25
19.04
1 125.28
-19.98
42.22
83.53
Profitability ratios
Return on assets %
0.03
-0
-0.06
-0.13
-0.05
0.05
Return on equity %
0.04
-0
-0.08
-0.23
-0.08
0.08
Return on invested capital %
18.3
3.66
-26.46
-59.17
-15.87
21.66
Gross margin %
44.73
44.98
41.19
22.15
29.97
164.75
Operating margin %
9
1.34
-12.38
-32.9
-6.19
31.07
EBITDA margin %
6.3
14.13
0.21
-17.22
4.11
72.01
Net margin %
6.66
-0.41
-13.43
-33.05
-8.14
29.82
Liquidity ratios
Quick ratio
4.55
5.2
2.59
0.92
1.8
7.76
Current ratio
5.5
6.42
4.56
2.78
3.41
15.59
Inventory turnover
3.68
4.09
2.39
1.96
2.49
—
Asset turnover
0.39
0.45
0.42
0.39
0.6
0.61
Solvency ratios
Debt to assets ratio
—
—
—
0.51
—
—
Debt to equity ratio
—
—
—
0.89
—
—
Long term debt to total assets ratio
0.22
0.19
0.2
0.27
0.23
0.81
Long term debt to total equity ratio
0.31
0.26
0.3
0.48
0.38
1.28
Per share metrics
Operating cash flow per share
0.18
0.13
-0.2
-0.6
0.04
0.22
EBIT per share
-0.19
0.03
-0.32
-0.74
-0.2
0.27
EBITDA per share
0.13
0.36
0.01
-0.39
0.13
0.58
Total debt per share
—
—
—
2.88
—
—
Cash per share
1.1
1.34
0.75
0.13
0.03
0.52
Net current asset value per share
1.69
2.14
1.81
1.51
1.84
7.37
Tangible book value per share
3.89
4.27
3.9
3.21
3.36
13.15
Working capital per share
1.38
1.81
1.41
0.97
1.3
5.47
Book value per share
3.92
4.29
3.92
3.23
3.37
13.2
뉴스
ImmuCell, 2026년 연례 주총서 이사진 교체 예정
ImmuCell directors to step down at 2026 annual meeting, board changes expected
이뮤셀, 새로운 경영진 고용 계약 및 스톡옵션 부여 발표
ImmuCell announces new executive employment agreements and option grants
Niche Focus & Regulation Shape the Future of Healthcare Firms
ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
ImmuCell 2025년 4분기 실적 발표 후 주가 상승세
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement
임뮤셀, 4분기 매출 760만 달러...First Defense에 집중
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense
ImmuCell Puts Re-Tain On Pause After FDA Letter - ImmuCell (NASDAQ:ICCC)
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio